Competitive gonadoliberin antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 8, 530328, C07K 706, A61K 3702

Patent

active

050718363

ABSTRACT:
Peptides of the formula

REFERENCES:
patent: 4118483 (1978-10-01), Konig et al.
patent: 4504467 (1985-03-01), Molloy et al.
patent: 4530920 (1985-07-01), Nestor et al.
patent: 4569927 (1986-02-01), Rivier et al.
Folkers et al., Z. Naturforsch, 42b, (1987), 101-106.
Ljungqvist et al., Biochem. Biophys. Res. Commun., 148, (1987), 849-856.
Bajusz et al., Proc. Natl. Acad. Sci., U.S.A., 85, (1988), 1637-1641.
Hocart et al., J. Med. Chem., 30, (1987), 735-739.
Nestor, Jr. et al., LHRH and its Derivatives, pp. 24-35 (1984).
Dutta, Drugs of the Future, vol. 13, No. 8, pp. 761-787 (1988).
Phillips et al., Life Sciences, vol. 41, No. 17, pp. 2017-2022 (1987).
Nestor, Jr. et al., J. Med. Chem., vol. 31, No. 1, pp. 65-72, (1988).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Competitive gonadoliberin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Competitive gonadoliberin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Competitive gonadoliberin antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1040710

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.